Get the Stockscreener App
0.6043
8.71%
0.0484
After Hours:
.58
-0.0243
-4.02%
Geovax Labs Inc stock is traded at $0.6043, with a volume of 1.45M.
It is up +8.71% in the last 24 hours and down -13.91% over the past month.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
See More
Previous Close:
$0.5559
Open:
$0.55
24h Volume:
1.45M
Relative Volume:
1.42
Market Cap:
$15.32M
Revenue:
$356.60K
Net Income/Loss:
$-24.32M
P/E Ratio:
-0.0654
EPS:
-9.24
Net Cash Flow:
$-27.24M
1W Performance:
+9.36%
1M Performance:
-13.91%
6M Performance:
-43.52%
1Y Performance:
-69.94%
1-Day Range:
$0.545
$0.6159
1-Week Range:
$0.52
$0.6174
52-Week Range:
$0.43
$3.70
Geovax Labs Inc Stock (GOVX) Company Profile
Name
Geovax Labs Inc
Sector
Industry
Phone
678-384-7220
Address
1900 LAKE PARK DRIVE, SMYRNA
Compare GOVX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
0.6043 | 16.51M | 356.60K | -24.32M | -27.24M | -9.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-25 | Reiterated | Alliance Global Partners | Buy |
| Apr-15-25 | Reiterated | D. Boral Capital | Buy |
| Nov-11-24 | Initiated | Alliance Global Partners | Buy |
| Jul-16-24 | Initiated | ROTH MKM | Buy |
| Nov-19-20 | Initiated | Maxim Group | Buy |
Geovax Labs Inc Stock (GOVX) Latest News
Custom watchlist performance reports with GeoVax Labs Inc.Weekly Trade Analysis & Accurate Technical Buy Alerts - newser.com
Is GeoVax Labs Inc. stock supported by strong fundamentals2025 Retail Activity & Fast Exit Strategy with Risk Control - newser.com
Key metrics from GeoVax Labs Inc. Equity Warrant’s quarterly data2025 Top Gainers & Verified Entry Point Signals - newser.com
Is GeoVax Labs Inc. Equity Warrant stock a contrarian buyJuly 2025 Short Interest & Breakout Confirmation Trade Signals - newser.com
Is GeoVax Labs Inc. forming a bottoming baseEarnings Trend Report & Long-Term Growth Portfolio Plans - newser.com
What moving averages say about GeoVax Labs Inc. Equity WarrantJuly 2025 Review & Capital Protection Trading Alerts - newser.com
Why GeoVax Labs Inc. stock could be next big winner2025 Risk Factors & Trade Opportunity Analysis Reports - newser.com
Does GeoVax Labs Inc. fit your quant trading model2025 Price Action Summary & Safe Entry Zone Tips - newser.com
Real time scanner hits for GeoVax Labs Inc. explained2025 Top Decliners & Step-by-Step Swing Trade Plans - newser.com
Can GeoVax Labs Inc. Equity Warrant stock hit analyst price targets2025 Investor Takeaways & Capital Efficiency Focused Strategies - newser.com
Is GeoVax Labs Inc. Equity Warrant stock affected by interest rate hikesJuly 2025 Final Week & AI Driven Stock Movement Reports - newser.com
GeoVax Executives to Pursue European Partnerships for Vaccine and Cancer Therapy Development - citybuzz
Historical volatility pattern of GeoVax Labs Inc. visualizedTrade Signal Summary & Weekly High Return Stock Forecasts - newser.com
GeoVax Leadership to Participate in Key European Meetings to Advance Partnering Discussions - Yahoo Finance
How to monitor GeoVax Labs Inc. Equity Warrant with trend dashboardsJuly 2025 Outlook & Long Hold Capital Preservation Plans - newser.com
Price action breakdown for GeoVax Labs Inc. Equity Warrant2025 Market Overview & Real-Time Volume Analysis Alerts - newser.com
Chart based analysis of GeoVax Labs Inc. Equity Warrant trendsPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
Comparing GeoVax Labs Inc. in custom built stock radarsQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Will GeoVax Labs Inc. continue its uptrendQuarterly Portfolio Report & Consistent Growth Equity Picks - newser.com
GeoVax Labs Inc Stock Analysis and ForecastInstitutional Holding Changes & Budget Friendly Trading Strategies - earlytimes.in
Statistical indicators supporting GeoVax Labs Inc.’s strengthPortfolio Performance Summary & Community Driven Trade Alerts - newser.com
Why GeoVax Labs Inc. Equity Warrant stock attracts global investorsEarnings Recap Summary & High Conviction Buy Zone Alerts - newser.com
Will GeoVax Labs Inc. Equity Warrant see short term momentumEarnings Recap Report & AI Forecast Swing Trade Picks - newser.com
GeoVax Labs Inc. stock trend forecastJuly 2025 Opening Moves & Stock Market Timing Techniques - newser.com
GeoVax to Present COVID-19 Vaccine Data for Immunocompromised Patients at European Vaccine Congress - citybuzz
GeoVax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2025 - Yahoo Finance
Can trapped investors hope for a rebound in GeoVax Labs Inc.2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Published on: 2025-10-09 06:58:36 - newser.com
What candlestick patterns are forming on GeoVax Labs Inc.Trade Analysis Report & Expert Curated Trade Setup Alerts - newser.com
Backtesting results for GeoVax Labs Inc. Equity Warrant trading strategiesJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com
GeoVax CEO to Present Pipeline Progress at ROTH Healthcare Conference - citybuzz
GeoVax to Participate in the 4th Annual ROTH Healthcare Opportunities Conference - Yahoo Finance
GeoVax Labs Raises $2.5 Million in Direct Offering - MSN
Trend analysis for GeoVax Labs Inc. Equity Warrant this weekOil Prices & High Return Trade Opportunity Guides - newser.com
Is GeoVax Labs Inc. stock undervalued vs historical averages2025 Earnings Impact & Precise Swing Trade Alerts - newser.com
What margin trends mean for GeoVax Labs Inc. stockInsider Buying & Short-Term Trading Alerts - newser.com
Using data tools to time your GeoVax Labs Inc. Equity Warrant exit2025 Price Targets & AI Optimized Trading Strategy Guides - newser.com
Does GeoVax Labs Inc. Equity Warrant stock trade at a discount to peersPortfolio Gains Summary & Free Community Supported Trade Ideas - newser.com
How sentiment analysis helps forecast GeoVax Labs Inc. Equity Warrant2025 Dividend Review & Community Driven Trade Alerts - newser.com
Geovax Labs Inc Stock (GOVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Geovax Labs Inc Stock (GOVX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SPENCER JOHN N JR | Director |
Apr 10 '25 |
Buy |
0.98 |
10,000 |
9,800 |
11,402 |
| Sharkey John W. | VP, Business Development |
Apr 10 '25 |
Buy |
0.99 |
6,000 |
5,940 |
6,191 |
| DODD DAVID A | President, CEO |
Apr 01 '25 |
Buy |
1.08 |
10,000 |
10,800 |
36,661 |
| Reynolds Mark | CFO |
Mar 31 '25 |
Buy |
1.08 |
6,800 |
7,343 |
14,013 |
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):